Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026)

Camp4 Therapeutics (CAMP) posted Assets Average of $111.6 million for Q1 2026, up 9.33% sequentially from $102.1 million in Q4 2025, and up 58.25% YoY from $70.5 million in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Assets Average for 3 years, with the latest figure at $111.6 million in Q1 2026.

  • Quarterly Assets Average rose 58.25% year-over-year to $111.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.6 million (up 58.25% YoY) and the FY2025 annual result came in at $98.1 million, up 47.17% from the prior year.
  • Assets Average grew to $111.6 million in Q1 2026 per CAMP's latest filing, from $102.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $111.6 million in Q1 2026 and troughed at $49.8 million in Q4 2024.
  • A 3-year average of $76.7 million and a median of $69.7 million in 2025 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2025 and 2026: Assets Average surged 104.88% in 2025, then jumped 58.25% in 2026.
  • Over 3 years, Assets Average stood at $49.8 million in 2024, then jumped by 104.88% to $102.1 million in 2025, then gained by 9.33% to $111.6 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $111.6 million, $102.1 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - 99.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99.44 Mn
Mar 31, 2026 111.63 Mn
Dec 31, 2025 102.10 Mn
Sep 30, 2025 68.84 Mn
Jun 30, 2025 57.02 Mn
Mar 31, 2025 70.54 Mn
Dec 31, 2024 49.84 Mn